Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
49
OXY Quote, Financials, Valuation and Earnings
Last price:
$48.82
Seasonality move
:
7.78%
Day range:
$49.02 - $50.17
52-week range:
$44.70 - $71.19
Dividend yield:
1.82%
P/E ratio:
20.29x
P/S ratio:
1.79x
P/B ratio:
1.80x
Volume:
10.8M
Avg. volume:
12.8M
1-year change:
-22.88%
Market cap:
$46.5B
Revenue:
$26.7B
EPS (TTM):
$2.44
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.8B | $26B | $36.6B | $28.3B | $26.7B | |
| Revenue Growth (YoY) | -14.83% | 45.75% | 41.14% | -22.87% | -5.42% | |
| Cost of Revenues | $16.6B | $18.1B | $19B | $18.1B | $17.2B | |
| Gross Profit | $1.2B | $7.9B | $17.6B | $10.1B | $9.6B | |
| Gross Profit Margin | 6.99% | 30.24% | 48.17% | 35.78% | 35.73% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $864M | $863M | $945M | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$13.1B | $488M | $1.3B | $821M | -$519M | |
| Operating Expenses | $2.5B | $3.2B | $4B | $3.7B | $4B | |
| Operating Income | -$1.3B | $4.7B | $13.7B | $6.4B | $5.6B | |
| Net Interest Expenses | $1.3B | $1.4B | $877M | $806M | $1B | |
| EBT. Incl. Unusual Items | -$15.7B | $3.7B | $14.1B | $6.4B | $4.1B | |
| Earnings of Discontinued Ops. | -$1.3B | -$468M | -- | -- | $182M | |
| Income Tax Expense | -$2.2B | $915M | $813M | $1.7B | $1.2B | |
| Net Income to Company | -$14.8B | $2.3B | $13.3B | $4.7B | $3.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$22M | |
| Net Income to Common Excl Extra Items | -$14.8B | $2.3B | $13.3B | $4.7B | $3.1B | |
| Basic EPS (Cont. Ops) | -$17.06 | $1.62 | $13.41 | $4.22 | $2.59 | |
| Diluted EPS (Cont. Ops) | -$17.06 | $1.58 | $12.40 | $3.90 | $2.44 | |
| Weighted Average Basic Share | $918.7M | $935M | $926.2M | $889.2M | $911.8M | |
| Weighted Average Diluted Share | $918.7M | $958.8M | $1B | $960.9M | $967.1M | |
| EBITDA | -$6.2B | $13.8B | $22.1B | $14.2B | $12.6B | |
| EBIT | -$14.3B | $5.3B | $15.1B | $7.4B | $5.2B | |
| Revenue (Reported) | $17.8B | $26B | $36.6B | $28.3B | $26.7B | |
| Operating Income (Reported) | -$1.3B | $4.7B | $13.7B | $6.4B | $5.6B | |
| Operating Income (Adjusted) | -$14.3B | $5.3B | $15.1B | $7.4B | $5.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $7.9B | $8.2B | $7.2B | $6.8B | |
| Revenue Growth (YoY) | -37.24% | 90.22% | 3.87% | -12.74% | -5.75% | |
| Cost of Revenues | $3.8B | $4.6B | $4.8B | $4.8B | $4.4B | |
| Gross Profit | $316M | $3.3B | $3.5B | $2.4B | $2.3B | |
| Gross Profit Margin | 7.6% | 41.6% | 42.17% | 33.66% | 34.29% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $209M | $280M | $258M | $307M | $276M | |
| Other Inc / (Exp) | -$629M | $514M | $261M | $442M | -$1.1B | |
| Operating Expenses | $733M | $952M | $1.1B | $1.1B | $1.1B | |
| Operating Income | -$417M | $2.3B | $2.4B | $1.3B | $1.2B | |
| Net Interest Expenses | $379M | $361M | $229M | $215M | $286M | |
| EBT. Incl. Unusual Items | -$1.4B | $2.5B | $2.4B | $1.6B | -$169M | |
| Earnings of Discontinued Ops. | $37M | -$24M | -- | -- | -- | |
| Income Tax Expense | -$276M | $469M | $473M | $361M | -$49M | |
| Net Income to Company | -$1.1B | $1.5B | $1.9B | $1.2B | -$120M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$7M | |
| Net Income to Common Excl Extra Items | -$1.1B | $1.5B | $1.9B | $1.2B | -$127M | |
| Basic EPS (Cont. Ops) | -$1.41 | $1.42 | $1.90 | $1.16 | -$0.32 | |
| Diluted EPS (Cont. Ops) | -$1.41 | $1.37 | $1.74 | $1.08 | -$0.32 | |
| Weighted Average Basic Share | $933.1M | $936.8M | $905.8M | $881.1M | $940.9M | |
| Weighted Average Diluted Share | $933.1M | $972.6M | $990.3M | $950.4M | $984.2M | |
| EBITDA | $738M | $4.8B | $4.5B | $3.5B | $2.1B | |
| EBIT | -$1B | $2.9B | $2.7B | $1.8B | $158M | |
| Revenue (Reported) | $4.2B | $7.9B | $8.2B | $7.2B | $6.8B | |
| Operating Income (Reported) | -$417M | $2.3B | $2.4B | $1.3B | $1.2B | |
| Operating Income (Adjusted) | -$1B | $2.9B | $2.7B | $1.8B | $158M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.8B | $26B | $36.6B | $28.3B | $26.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $16.6B | $18.1B | $19B | $18.1B | $17.2B | |
| Gross Profit | $1.2B | $7.9B | $17.6B | $10.1B | $9.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $864M | $863M | $945M | $1.1B | $1.1B | |
| Other Inc / (Exp) | -$13.2B | $488M | $1.3B | $821M | -$519M | |
| Operating Expenses | $2.5B | $3.2B | $4B | $3.7B | $4B | |
| Operating Income | -$1.3B | $4.7B | $13.7B | $6.4B | $5.6B | |
| Net Interest Expenses | $1.3B | $1.4B | $877M | $806M | $1B | |
| EBT. Incl. Unusual Items | -$15.8B | $3.7B | $14.1B | $6.4B | $4.1B | |
| Earnings of Discontinued Ops. | -$1.3B | -$468M | -- | -- | $182M | |
| Income Tax Expense | -$2.2B | $915M | $813M | $1.7B | $1.2B | |
| Net Income to Company | -$14.8B | $2.3B | $13.3B | $4.7B | $3.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -$22M | |
| Net Income to Common Excl Extra Items | -$14.8B | $2.3B | $13.3B | $4.7B | $3.1B | |
| Basic EPS (Cont. Ops) | -$17.09 | $1.62 | $13.36 | $4.22 | $2.62 | |
| Diluted EPS (Cont. Ops) | -$17.09 | $1.55 | $12.38 | $3.91 | $2.44 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$6.2B | $13.8B | $22.1B | $14.2B | $12.6B | |
| EBIT | -$14.3B | $5.3B | $15.1B | $7.4B | $5.2B | |
| Revenue (Reported) | $17.8B | $26B | $36.6B | $28.3B | $26.7B | |
| Operating Income (Reported) | -$1.3B | $4.7B | $13.7B | $6.4B | $5.6B | |
| Operating Income (Adjusted) | -$14.3B | $5.3B | $15.1B | $7.4B | $5.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $26B | $36.6B | $28.3B | $26.7B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.1B | $19B | $18.1B | $17.2B | -- | |
| Gross Profit | $7.9B | $17.6B | $10.1B | $9.6B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $863M | $945M | $1.1B | $1.1B | -- | |
| Other Inc / (Exp) | $488M | $1.3B | $821M | -$519M | -- | |
| Operating Expenses | $3.2B | $4B | $3.7B | $4B | -- | |
| Operating Income | $4.7B | $13.7B | $6.4B | $5.6B | -- | |
| Net Interest Expenses | $1.4B | $877M | $806M | $1B | -- | |
| EBT. Incl. Unusual Items | $3.7B | $14.1B | $6.4B | $4.1B | -- | |
| Earnings of Discontinued Ops. | -$468M | -- | -- | $182M | -- | |
| Income Tax Expense | $915M | $813M | $1.7B | $1.2B | -- | |
| Net Income to Company | $2.3B | $13.3B | $4.7B | $3.1B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -$22M | -- | |
| Net Income to Common Excl Extra Items | $2.3B | $13.3B | $4.7B | $3.1B | -- | |
| Basic EPS (Cont. Ops) | $1.62 | $13.36 | $4.22 | $2.62 | -- | |
| Diluted EPS (Cont. Ops) | $1.55 | $12.38 | $3.91 | $2.44 | -- | |
| Weighted Average Basic Share | $3.7B | $3.7B | $3.6B | $3.6B | -- | |
| Weighted Average Diluted Share | $3.8B | $4B | $3.8B | $3.9B | -- | |
| EBITDA | $13.8B | $22.1B | $14.2B | $12.6B | -- | |
| EBIT | $5.3B | $15.1B | $7.4B | $5.2B | -- | |
| Revenue (Reported) | $26B | $36.6B | $28.3B | $26.7B | -- | |
| Operating Income (Reported) | $4.7B | $13.7B | $6.4B | $5.6B | -- | |
| Operating Income (Adjusted) | $5.3B | $15.1B | $7.4B | $5.2B | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.8B | $984M | $1.4B | $2.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.1B | $4.2B | $4.3B | $3.2B | $3.5B | |
| Inventory | $1.9B | $1.8B | $2.1B | $2B | $2.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.2B | $1.4B | $1.6B | $830M | $597M | |
| Total Current Assets | $8.8B | $10.2B | $8.9B | $8.4B | $9.1B | |
| Property Plant And Equipment | $67B | $60.7B | $59.3B | $59.7B | $70.3B | |
| Long-Term Investments | $3.3B | $2.9B | $3.2B | $3.2B | $3.2B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1B | $1.2B | $1.3B | $2.8B | $2.9B | |
| Total Assets | $80.1B | $75B | $72.6B | $74B | $85.4B | |
| Accounts Payable | $3B | $3.9B | $4B | $3.6B | $3.8B | |
| Accrued Expenses | $3.6B | $4.1B | $3.3B | $1B | $1.1B | |
| Current Portion Of Long-Term Debt | $398M | $101M | $22M | $1.1B | $1B | |
| Current Portion Of Capital Lease Obligations | $515M | $271M | $416M | $592M | $509M | |
| Other Current Liabilities | $753M | -- | -- | $1.4B | $1.1B | |
| Total Current Liabilities | $8.2B | $8.3B | $7.8B | $9.1B | $9.5B | |
| Long-Term Debt | $35.4B | $28.9B | $19.1B | $17.9B | $24.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $61.5B | $54.7B | $42.5B | $43.7B | $51B | |
| Common Stock | $10B | $10B | $10B | $8.5B | $8.5B | |
| Other Common Equity Adj | -$288M | -$208M | $195M | $275M | $179M | |
| Common Equity | $8.8B | $10.6B | $20.3B | $22B | $25.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $99M | $321M | |
| Total Equity | $18.6B | $20.3B | $30.1B | $30.3B | $34.5B | |
| Total Liabilities and Equity | $80.1B | $75B | $72.6B | $74B | $85.4B | |
| Cash and Short Terms | $2B | $2.8B | $984M | $1.4B | $2.1B | |
| Total Debt | $35.8B | $29B | $19.1B | $19B | $25.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2B | $2.8B | $984M | $1.4B | $2.1B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2.1B | $4.2B | $4.3B | $3.2B | $3.5B | |
| Inventory | $1.9B | $1.8B | $2.1B | $2B | $2.1B | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.2B | $1.4B | $1.6B | $830M | $597M | |
| Total Current Assets | $8.8B | $10.2B | $8.9B | $8.4B | $9.1B | |
| Property Plant And Equipment | $67B | $60.7B | $59.3B | $59.7B | $70.3B | |
| Long-Term Investments | $3.3B | $2.9B | $3.2B | $3.2B | $3.2B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $1B | $1.2B | $1.3B | $2.8B | $2.9B | |
| Total Assets | $80.1B | $75B | $72.6B | $74B | $85.4B | |
| Accounts Payable | $3B | $3.9B | $4B | $3.6B | $3.8B | |
| Accrued Expenses | $3.6B | $4.1B | $3.3B | $1B | $1.1B | |
| Current Portion Of Long-Term Debt | $398M | $101M | $22M | $1.1B | $1B | |
| Current Portion Of Capital Lease Obligations | $515M | $271M | $416M | $592M | $509M | |
| Other Current Liabilities | $753M | -- | -- | $1.4B | $1.1B | |
| Total Current Liabilities | $8.2B | $8.3B | $7.8B | $9.1B | $9.5B | |
| Long-Term Debt | $35.4B | $28.9B | $19.1B | $17.9B | $24.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $61.5B | $54.7B | $42.5B | $43.7B | $51B | |
| Common Stock | $10B | $10B | $10B | $8.5B | $8.5B | |
| Other Common Equity Adj | -$288M | -$208M | $195M | $275M | $179M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | $99M | $321M | |
| Total Equity | $18.6B | $20.3B | $30.1B | $30.3B | $34.5B | |
| Total Liabilities and Equity | $80.1B | $75B | $72.6B | $74B | $85.4B | |
| Cash and Short Terms | $2B | $2.8B | $984M | $1.4B | $2.1B | |
| Total Debt | $35.8B | $29B | $19.1B | $19B | $25.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$14.8B | $2.3B | $13.3B | $4.7B | $3.1B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $2.1B | -$2.1B | -$432M | $1.1B | $170M | |
| Change in Inventories | -$484M | -$86M | -$230M | -$91M | -$46M | |
| Cash From Operations | $4B | $10.4B | $16.8B | $12.3B | $11.4B | |
| Capital Expenditures | $3.1B | $2.9B | $4.5B | $6.3B | $7B | |
| Cash Acquisitions | -$5M | $406M | -$116M | -$470M | -$212M | |
| Cash From Investing | -$819M | -$1.3B | -$4.9B | -$7B | -$14.6B | |
| Dividends Paid (Ex Special Dividend) | -$1.8B | -$839M | -$1.2B | -$1.4B | -$1.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.9B | -- | $400M | $900M | $9.6B | |
| Long-Term Debt Repaid | -$8.9B | -$6.8B | -$9.9B | -$968M | -$4.5B | |
| Repurchase of Common Stock | -$12M | -$8M | -$3.1B | -$3.5B | -$27M | |
| Other Financing Activities | -$805M | -$914M | -$241M | -$133M | -$365M | |
| Cash From Financing | -$4.5B | -$8.6B | -$13.7B | -$4.9B | $3.8B | |
| Beginning Cash (CF) | $3.6B | $2.2B | $2.8B | $1B | $1.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.4B | $609M | -$1.8B | $438M | $693M | |
| Ending Cash (CF) | $2.2B | $2.8B | $1B | $1.5B | $2.2B | |
| Levered Free Cash Flow | $901M | $7.6B | $12.3B | $6B | $4.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.1B | $1.5B | $1.9B | $1.2B | -$120M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2.2B | -$720M | -$570M | $466M | $702M | |
| Change in Inventories | -$242M | -$178M | -$134M | -$47M | $180M | |
| Cash From Operations | $1.4B | $3.1B | $4B | $3.2B | $3.4B | |
| Capital Expenditures | $408M | $937M | $1.5B | $1.5B | $1.8B | |
| Cash Acquisitions | -$91M | $549M | $445M | -$48M | -$63M | |
| Cash From Investing | $1.6B | -$51M | -$1.9B | -$2B | -$1.8B | |
| Dividends Paid (Ex Special Dividend) | -$211M | -$209M | -$321M | -$330M | -$377M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2B | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$4.3B | -$2.3B | -$1.2B | -$46M | -$507M | |
| Repurchase of Common Stock | -$12M | -$8M | -$632M | -$187M | -$18M | |
| Other Financing Activities | -$325M | -$42M | -$220M | $65M | -$313M | |
| Cash From Financing | -$2.9B | -$2.5B | -$2.3B | -$455M | -$1.2B | |
| Beginning Cash (CF) | $2.1B | $2.3B | $1.3B | $649M | $1.8B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $120M | $509M | -$253M | $815M | $364M | |
| Ending Cash (CF) | $2.2B | $2.8B | $1B | $1.5B | $2.2B | |
| Levered Free Cash Flow | $996M | $2.2B | $2.5B | $1.7B | $1.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$14.8B | $2.3B | $13.3B | $4.7B | $3.1B | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $2.1B | -$2.1B | -$432M | $1.1B | $170M | |
| Change in Inventories | -$484M | -$86M | -$230M | -$91M | -$46M | |
| Cash From Operations | $4B | $10.4B | $16.8B | $12.3B | $11.4B | |
| Capital Expenditures | $3.1B | $2.9B | $4.5B | $6.3B | $7B | |
| Cash Acquisitions | -$5M | $406M | -$116M | -$470M | -$212M | |
| Cash From Investing | -$819M | -$1.3B | -$4.9B | -$7B | -$14.6B | |
| Dividends Paid (Ex Special Dividend) | -$1.8B | -$839M | -$1.2B | -$1.4B | -$1.4B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$8.9B | -$6.8B | -$9.9B | -$968M | -$4.5B | |
| Repurchase of Common Stock | -- | -$8M | -$3.1B | -$3.5B | -$27M | |
| Other Financing Activities | -$805M | -$914M | -$241M | -$133M | -$365M | |
| Cash From Financing | -$4.5B | -$8.6B | -$13.7B | -$4.9B | $3.8B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$1.4B | $609M | -$1.8B | $438M | $693M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $901M | $7.6B | $12.3B | $6B | $4.4B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $13.3B | $4.7B | $3.1B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$2.1B | -$432M | $1.1B | $170M | -- | |
| Change in Inventories | -$86M | -$230M | -$91M | -$46M | -- | |
| Cash From Operations | $10.4B | $16.8B | $12.3B | $11.4B | -- | |
| Capital Expenditures | $2.9B | $4.5B | $6.3B | $7B | -- | |
| Cash Acquisitions | $406M | -$116M | -$470M | -$212M | -- | |
| Cash From Investing | -$1.3B | -$4.9B | -$7B | -$14.6B | -- | |
| Dividends Paid (Ex Special Dividend) | -$839M | -$1.2B | -$1.4B | -$1.4B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $400M | $900M | $9.6B | -- | |
| Long-Term Debt Repaid | -$6.8B | -$9.9B | -$968M | -$4.5B | -- | |
| Repurchase of Common Stock | -$8M | -$3.1B | -$3.5B | -$27M | -- | |
| Other Financing Activities | -$914M | -$241M | -$133M | -$365M | -- | |
| Cash From Financing | -$8.6B | -$13.7B | -$4.9B | $3.8B | -- | |
| Beginning Cash (CF) | $11.7B | $7.4B | $3.4B | $6.5B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $609M | -$1.8B | $438M | $693M | -- | |
| Ending Cash (CF) | $12.3B | $5.7B | $3.9B | $7.2B | -- | |
| Levered Free Cash Flow | $7.6B | $12.3B | $6B | $4.4B | -- | |
Get OXY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OXY
Sector
P/E ratio
20.29x
11.14x
PEG ratio
--
0.02x
P/B ratio
1.80x
1.07x
Price / LTM sales
1.79x
0.92x
Growth Metrics
OXY
Sector
Revenue growth
-5.75%
-4%
Earnings growth
-18.33%
-20.83%
Revenue (5-year growth)
5.03%
6.7%
Earnings forecast
$0.67
$0.22
Profitability
OXY
Sector
Profitability FY 2024
$9.6B
$108.4M
Return on invested capital
5.64%
3.75%
Return on assets
3.86%
2.52%
Return on equity
9.38%
5.78%
Earnings Date
Last Earnings Date
Feb
18
Next Earnings Date
May
7
Estimated Next Earnings Date
May
20
Balance Sheet
OXY
Sector
Total cash
$2.1B
$14.9M
Short term investments
--
$4M
Total assets
$85.4B
$404.6M
Long term debt
$25.3B
$122.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
